Has Yiming Yang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $35,657 in general payments to Yiming Yang, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yiming Yang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yiming Yang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yiming Yang, MD

Cardiovascular Disease · Brooklyn, NYNPI 1467472746

Payments from drug & device makers

$35,657in general payments, 2019–2025

Across 45 payments — averaging $792.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Contego Medical, Inc$29K
Microvention, Inc.$2K
Boston Scientific$1K
Inari Medical, Inc.$916
Abbott$740
Medtronic$598
plus $767 from 7 others

What the payments were for

Travel & lodging$1,47635%
Food & beverage$2,75265%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Contego Medical, Inc	5	$29,448
Microvention, Inc.	1	$2,000
Boston Scientific	11	$1,189
Inari Medical, Inc.	2	$916
Abbott	7	$740
Medtronic(2 entities)	6	$598
Cardiovascular Systems Inc.	5	$279
Integra Lifesciences Corporation	1	$147
Esperion Therapeutics, Inc.	2	$137
Amgen	1	$125
Merck	2	$44
GSK	1	$18
Zimvie Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FlowTriever$916
ClotTriever$916
GENERAL - THERAPIES$560
AVEIR$388
CoreValve Evolut$346
Peripheral Orbital Atherectomy System$233
Coronary Orbital Atherectomy System$233
SYMPLICITY G3$178
Assurity Pacemaker$176
PROMUS$148
BILAYER WOUND MATRIX (BWM)$147
INTEGRA WOUND MATRIX (IWM)$147
PRIMATRIX$147
IDRT$147
FLOWABLE$147
Supera peripheral stent system$144
Repatha$125
GENERAL VASCULAR INTERVENTION$121
ROTAPRO$120
NEXLIZET$117

How this compares

$35,657 in reported general payments places this provider in the 85th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$115,798

Medicare patients

138

Services billed

830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	276	$259,256
JardianceEmpagliflozin	185	$203,492
EntrestoSacubitril/Valsartan	83	$93,898
FarxigaDapagliflozin Propanediol	28	$35,348
XareltoRivaroxaban	19	$21,925
MultaqDronedarone Hcl	14	$17,847
BrilintaTicagrelor	28	$16,320
DapagliflozinDapagliflozin Propanediol	17	$8,678
Metoprolol Succinate	758	$8,515
Atorvastatin Calcium	800	$8,265
Amlodipine-ValsartanAmlodipine Besylate/Valsartan	144	$6,238
Ranolazine ErRanolazine	84	$5,340
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	290	$5,312
Amlodipine Besylate	683	$4,952
Nebivolol Hcl	69	$4,010

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Brooklyn

Ronald WhartonBrooklyn$1.1M
Ozgen DoganBrooklyn$404K
Warren WexelmanBrooklyn$396K
James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Vijay IyerAmherst$4.3M
Gregg StoneNew York$3.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →